Literature DB >> 1568533

Correlates of brain edema in uncontrolled IDDM.

J A Durr1, W H Hoffman, A H Sklar, T el Gammal, C M Steinhart.   

Abstract

Blood glucose, plasma sodium, bicarbonate (HCO3-), vasopressin, and hematocrit were monitored before and during treatment in patients with uncontrolled insulin-dependent diabetes mellitus (IDDM). These parameters were correlated with simultaneous serial cranial computed tomography readings of brain edema. Six of seven patients had positive computed tomography readings for brain edema on admission. Initial brain edema correlated directly with blood glucose (r = 0.79, P = 0.033) and inversely with HCO3- (r = -0.76, P = 0.047). At 6 h, brain edema still correlated with acidosis (HCO3-; r = -0.79, P = 0.033) but no longer with blood glucose. At that time, however, brain edema correlated with the rate of change in blood glucose (r = 0.915, P = 0.005). Results of interactive stepwise regression analysis suggest that the change in the calculated effective plasma osmolality plays a predominant role in the progression of brain edema during therapy (r = 0.995, P less than 0.001). Thus, although hyperglycemia and acidosis probably predispose to diabetic brain edema, osmotic factors may be major predictors of its evolution. No relationships were detected between brain edema and initiation of insulin therapy, plasma vasopressin, or changes in hematocrit. The factors responsible for initial brain edema and its progression, statistically identified in this study, require reassessment of common theories that attribute brain edema exclusively to therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1568533     DOI: 10.2337/diab.41.5.627

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Cerebral oedema in childhood diabetic ketoacidosis: is treatment a factor?

Authors:  T B Brown
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

2.  Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Manuel F Casanova; Cornelia D Cudrici; Ekaterina Zakranskaia; Roopa Venugopalan; Sukriti Nag; Michael J Oglesbee; Horea Rus
Journal:  Exp Mol Pathol       Date:  2007-01-30       Impact factor: 3.362

3.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 4.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

5.  Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes.

Authors:  Patrick J Troy; Roger P Clark; Sri G Kakarala; Jocelyn Burns; Isaac E Silverman; Eric Shore
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

6.  Causes of death in children with insulin dependent diabetes 1990-96.

Authors:  J A Edge; M E Ford-Adams; D B Dunger
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 7.  Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis.

Authors:  A P C P Carlotti; D Bohn; M L Halperin
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

Review 8.  ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents.

Authors:  D B Dunger; M A Sperling; C L Acerini; D J Bohn; D Daneman; T P A Danne; N S Glaser; R Hanas; R L Hintz; L L Levitsky; M O Savage; R C Tasker; J I Wolfsdorf
Journal:  Arch Dis Child       Date:  2004-02       Impact factor: 3.791

Review 9.  Hyperglycaemic crises and lactic acidosis in diabetes mellitus.

Authors:  P English; G Williams
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

Review 10.  Cerebral edema in children with diabetic ketoacidosis.

Authors:  N Glaser
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.